Targeting glucocerebrosidase with structurally targeted allosteric regulators corrects abnormal phenotypes in models of Parkinson’s disease
- Details
- Written by: web web
- Category: Events
- Hits: 771
Event
April 12th- 15th 2022 11:20 – 11:50 a.m. ET
April 12th- 15th 2022 11:20 – 11:50 a.m. ET
©2023 Gain Therapeutics, Inc.
Website by Sandman Media Inc.